Working toward earlier warning of IBD flares.
Working toward earlier warning of IBD flares.
We’re developing AI to study whether wearable data and symptom reports can help identify flares in Crohn’s disease and ulcerative colitis earlier.
Explore FutureFlare
Partnering with H2U on early exploratory development.
Semifinalist, 2025 Global Health Innovation Grand Challenge.
We’re developing AI to study whether wearable data and symptom reports can help identify flares in Crohn’s disease and ulcerative colitis earlier.
What we’re studying.
Our research focuses on Crohn’s disease and ulcerative colitis. We’re studying information collected in everyday life alongside symptom reports, with the aim of understanding changes in disease activity.
The next step is to evaluate the approach prospectively with clinical collaborators.
Where we are today
We’re working with H2U, a Taiwanese digital health technology company, on early exploratory development. FutureFlare was a semifinalist in the 2025 Global Health Innovation Grand Challenge and pitched in Taiwan.
We’re preparing for prospective clinical validation. Clinical performance has not yet been established.
